Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Ted Cohen"'
Autor:
Ted Cohen, Caroline O. Buckee, Nicolas A Menzies, Nishant Kishore, Pierre Jacob, Aimee R. Taylor, Navin Vembar
Publikováno v:
The Lancet. Digital Health
Summary Background In early 2020, the response to the SARS-CoV-2 pandemic focused on non-pharmaceutical interventions, some of which aimed to reduce transmission by changing mixing patterns between people. Aggregated location data from mobile phones
Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United States
Autor:
Ardath Grills, Andrew N. Hill, Susan A. Maloney, Ted Cohen, Joshua A. Salomon, Anand Date, Suzanne M. Marks, Christian Testa, Sarah Bowden, Nicolas A Menzies, Nicole A Swartwood, Yelena Malyuta, Meghan Bellerose
Publikováno v:
American Journal of Respiratory and Critical Care Medicine
Rationale: Most U.S. residents who develop tuberculosis (TB) were born abroad, and U.S. TB incidence is increasingly driven by infection risks in other countries. Objectives: To estimate the potential impact of effective global TB control on health a
Autor:
Ted Cohen, Hao-Yuan Cheng, Ta-Chou Ng, Chih-Chi Yang, Hsiao-Han Chang, Hsien-Ho Lin, Ding-Ping Liu, Cheng-Chieh Liu, Shu-Wan Jian
Publikováno v:
JAMA Internal Medicine.
Importance Taiwan is one of the few countries with initial success in COVID-19 control without strict lockdown or school closure. The reasons remain to be fully elucidated. Objective To compare and evaluate the effectiveness of case-based (including
Autor:
Joshua L. Warren, Ted Cohen, Virginia E. Pitzer, Nicolas A Menzies, Daniel M. Weinberger, Stephanie Perniciaro, Melanie H. Chitwood, Joshua Havumaki
Publikováno v:
medRxiv
article-version (status) pre
article-version (number) 1
American Journal of Epidemiology
article-version (status) pre
article-version (number) 1
American Journal of Epidemiology
Estimates of the reproductive number for novel pathogens such as SARS-CoV-2 are essential for understanding the potential trajectory of the epidemic and the level of intervention that is needed to bring the epidemic under control. However, most metho
Autor:
Nicolas A Menzies, Florian M. Marx, Grant Theron, Ted Cohen, Joshua A. Salomon, Reza Yaesoubi
Publikováno v:
The Lancet Global Health, Vol 8, Iss 9, Pp e1223-e1233 (2020)
Lancet Glob Health
Lancet Glob Health
Summary Background In settings of high tuberculosis incidence, previously treated individuals remain at high risk of recurrent tuberculosis and contribute substantially to overall disease burden. Whether tuberculosis case finding and preventive inter
Autor:
Ted Cohen, Harrell W. Chesson, Joshua A. Salomon, Katherine K. Hsu, Thomas L. Gift, Reza Yaesoubi, Yonatan H. Grad
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 17, Iss 4, p e1003077 (2020)
PLoS Medicine, Vol 17, Iss 4, p e1003077 (2020)
Background The rise of gonococcal antimicrobial resistance highlights the need for strategies that extend the clinically useful life span of antibiotics. Because there is limited evidence to support the current practice of switching empiric first-lin
Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model
Autor:
Suzanne M. Marks, Ted Cohen, Nicolas A Menzies, Reza Yaesoubi, Kara Galer, Joshua A. Salomon, Andrew N. Hill, Emory E Wolf
Publikováno v:
Am J Epidemiol
We estimated long-term tuberculosis (TB) trends in the US population and assessed prospects for TB elimination. We used a detailed simulation model allowing for changes in TB transmission, immigration, and other TB risk determinants. Five hypothetica
Publikováno v:
AIDS. 30:2715-2723
Objective Extending the duration of isoniazid preventive therapy (IPT) among people living with HIV (PLHIV) may improve its effectiveness at both individual and population levels, but could also increase selective pressure in favor of isoniazid-resis
Autor:
Nimalan Arinaminpathy, Vineet K. Chadha, Tom Sumner, Marcus W. Feldman, Suvanand Sahu, Yogan Pillay, Carel Pretorius, Ted Cohen, Piotr Hippner, Emma S. McBryde, Philip A. Eckhoff, Lucica Ditiu, Jeffrey W. Eaton, Grace H. Huynh, Mehran Hosseini, Michael E. Kimerling, Joshua A. Salomon, Sze-chuan Suen, Andrew S. Azman, Gabriela B. Gomez, L. David Mametja, Sandip Mandal, Justin T Denholm, Allison S. Rhines, Marek Lalli, Gavin J. Churchyard, Rein M G J Houben, Richard G. White, Salome Charalambous, Jeremy D. Goldhaber-Fiebert, Hsien-Ho Lin, Stewart T. Chang, Lixia Wang, James M. Trauer, Daniel P. Chin, Nicolas Bacaër, Chieh Yin Wu, Anna Vassall, Alison D. Grant, David W. Dowdy, Kiran Rade, Colleen Daniels, Surabhi Pandey, Christopher C. Whalen, Eran Bendavid, Andreas Handel, Delia Boccia, Puneet Dewan, Nicolas A Menzies, Bradley G. Wagner
Publikováno v:
lancet global health, 4(11), e806-e815. Elsevier BV
The Lancet. Global Health
e815
e806
The Lancet Global Health, Vol 4, Iss 11, Pp e806-e815 (2016)
The Lancet. Global Health
e815
e806
The Lancet Global Health, Vol 4, Iss 11, Pp e806-e815 (2016)
Summary Background The post-2015 End TB Strategy proposes targets of 50% reduction in tuberculosis incidence and 75% reduction in mortality from tuberculosis by 2025. We aimed to assess whether these targets are feasible in three high-burden countrie
Publikováno v:
Addiction
Background and aims: Although opioid agonist treatment (OAT) for opioid use disorder (OUD) is cost-effective in settings where the HIV epidemic is concentrated among people who inject drugs, OAT coverage in Ukraine remains far below internationally r